癌症化疗期间的运动:系统性审查
R C Walker1,2, P Pezeshki1,3, S Barman1,4
1Guy's & St Thomas' Oesophago-gastric Centre, London, UK.
Journal of surgical oncology
|October 24, 2024
概括
运动预康复可以提高化疗的耐受性和有效性. 这种干预改善了癌症患者的身体组成,健康,力量和生活质量 (QoL),提供了安全有效的支持性护理策略.
科学领域:
- 在瘤学瘤学.
- 运动科学 运动科学
- 癌症康复 癌症康复
背景情况:
- 像化疗这样的抗癌治疗对患者来说可能是具有挑战性的.
- 建议进行运动预康复,以减轻治疗副作用并改善治疗结果.
- 了解癌症治疗期间运动的具体益处至关重要.
研究的目的:
- 系统地审查运动对化疗结果的影响.
- 确定运动瘤学的研究缺口和优先事项.
主要方法:
- 进行了对19项研究 (1418名患者) 的系统审查.
- 包括的研究包括11项随机对照试验和8项观察性研究.
- 分析了关于身体组成,健身,力量和生活质量的数据.
主要成果:
- 运动干预表明身体组成,健身和力量的显著改善.
- 化疗期间的运动对生活质量 (QoL) 有积极影响.
- 运动被发现是安全有效的支持性护理策略.
结论:
- 运动预康复是接受化疗的患者的可行和有益的干预措施.
- 需要对更大,更精心设计的研究进行进一步的研究,以优化炼方案.
- 建议在未来的研究中对运动干预措施进行标准化.
相关概念视频
Cancer
51.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.8K
Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
937
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
937
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870


